StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) stock

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.82+0.11 (+6.43%)

Close on Nov 17, 2026Market cap $66.94MP/E –Yield –

Fortress Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Fortress Biotech's pe ratio was 0.6× on Nov 11, 2026, against 21.9× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−27.9
2025Dec 31, 202528.5×–

More Fortress Biotech figures

See a number that looks wrong?